ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

FARN Faron Pharmaceuticals Oy

137.50
-2.50 (-1.79%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Faron Pharmaceuticals Oy LSE:FARN London Ordinary Share FI4000153309 ORD NPV (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.50 -1.79% 137.50 135.00 140.00 140.00 135.00 140.00 40,251 14:16:06
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -28.73M -0.4177 -3.29 94.58M

Faron Pharmaceuticals Oy Holding(s) in Company (4177M)

28/07/2017 9:34am

UK Regulatory


TIDMFARN TIDMAV.

RNS Number : 4177M

Faron Pharmaceuticals Oy

28 July 2017

 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
-------------------------------------------------- 
 
 
 
 1. Identity of the issuer or                                       Faron Pharmaceuticals Oy 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
-----------------------------------------------------------------  -------------------------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
--------------------------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights 
--------------------------------------------------------------------  ----------------------------------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
--------------------------------------------------------------------  ----------------------------------- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
--------------------------------------------------------------------  ----------------------------------- 
 An event changing the breakdown of voting rights 
--------------------------------------------------------------------  ----------------------------------- 
 Other (please 
  specify): 
-----------------------------------------------------------  -------  ----------------------------------- 
 3. Full name of person(s)                                      Aviva plc & its subsidiaries 
  subject to the 
  notification obligation: 
  (iii) 
-------------------------------------------------------------  ------------------------------------------ 
 4. Full name of shareholder(s)                                 Registered Holder: 
  (if different from 3.):(iv) 
                                                                Chase (GA Group) Nominees Limited 
                                                                1,151,067* 
 
                                                                HSBC Global Custody Nominee 
                                                                (UK) Limited 302,062* 
 
                                                                State Street Nominees Limited 
                                                                35,452* 
                                                                * denotes direct interest 
                                                                Chase (GA Group) Nominees Limited 
                                                                57,059 
                                                                Chase Nominees Limited 35,158 
-------------------------------------------------------------  ------------------------------------------ 
 5. Date of the transaction                                     26 July 2017 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
-------------------------------------------------------------  ------------------------------------------ 
 6. Date on which issuer                                        27 July 2017 
  notified: 
-------------------------------------------------------------  ------------------------------------------ 
 7. Threshold(s) that is/are                                    6% to 5% Change at Combined 
  crossed or                                                     Interest Level. Figures are 
  reached: (vi, vii)                                             provided in accordance with 
                                                                 provisions of your company 
                                                                 articles and not in fulfilment 
                                                                 of the requirements of the 
                                                                 Transparency Directive. 
-------------------------------------------------------------  ------------------------------------------ 
 
 
 
 8. Notified details: 
-------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
-------------------------------------------------------------------------------------------------------------- 
 Class/type           Situation previous              Resulting situation after the 
  of                   to the triggering               triggering transaction 
  shares               transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
-------------------  ------------------------------  --------------------------------------------------------- 
                      Number              Number      Number        Number of               % of voting 
                       of                  of          of shares     voting                  rights (x) 
                       Shares              Voting                    rights 
                                           Rights 
-------------------  ------------------  ----------  ------------  ----------------------  ------------------- 
                                                      Direct        Direct      Indirect    Direct   Indirect 
                                                                     (xi)        (xii) 
-------------------  ------------------  ----------  ------------  ----------  ----------  -------  ---------- 
 Ordinary 
  Shares 
 
 
  FI4000153309        1,910,798           1,910,798   1,580,798     1,488,581   92,217      5.33%    0.33% 
                     ------------------  ----------  ------------  ----------  ----------  -------  ---------- 
 
 
 B: Qualifying Financial Instruments 
-------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
-------------------------------------------------------------------------------------------------------------- 
 Type of financial    Expiration          Exercise/                 Number of voting        % of voting 
  instrument           date                Conversion                rights that             rights 
                       (xiii)              Period (xiv)              may be 
                                                                     acquired if 
                                                                     the 
                                                                     instrument 
                                                                     is 
                                                                     exercised/ 
                                                                     converted. 
-------------------  ------------------  ------------------------  ----------------------  ------------------- 
 
 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
----------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
----------------------------------------------------------------------------------------------- 
 Type of financial   Exercise   Expiration   Exercise/     Number of voting     % of voting 
  instrument          price      date         Conversion    rights instrument    rights (xix, 
                                 (xvii)       period        refers to            xx) 
                                              (xviii) 
------------------  ---------  -----------  ------------  -------------------  ---------------- 
                                                                                Nominal   Delta 
------------------  ---------  -----------  ------------  -------------------  --------  ------ 
 
 Total (A+B+C) 
----------------------------------------------------------------------------------------------- 
 Number of voting rights                                   Percentage of voting rights 
--------------------------------------------------------  ------------------------------------- 
 1,580,798                                                 5.66% 
--------------------------------------------------------  ------------------------------------- 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
-------------------------------------------------------------------- 
      The voting rights are managed and controlled by Aviva 
       Investors Global Services Limited, with the following 
       chain of controlled undertakings:- 
 
       Aviva Investors Global Services Limited: 
        *    Aviva plc (Parent Company) 
 
 
        *    Aviva Group Holdings Limited (wholly owned subsidiary 
             of Aviva plc) 
 
 
        *    Aviva Investors Holdings Limited (wholly owned 
             subsidiary of Aviva Group Holdings Limited) 
 
 
        *    Aviva Investors Global Services Limited (wholly owned 
             subsidiary of Aviva Investors Holdings Limited) 
 
 Proxy Voting: 
-------------------------------------------------------------------- 
 10. Name of the proxy holder:                     See Section 4 
------------------------------------------------  ------------------ 
 11. Number of voting rights proxy 
  holder will cease 
  to hold: 
------------------------------------------------  ------------------ 
 12. Date on which proxy holder will 
  cease to hold 
  voting rights: 
------------------------------------------------  ------------------ 
 
 
 
  13. Additional information:      Figures are based on a total 
                                   number of voting rights of 
                                   27,914,544 as per the company's 
                                   Announcement of 1 June 2017. 
-------------------------------  --------------------------------- 
 14. Contact name:                Neil Whittaker, Aviva plc 
-------------------------------  --------------------------------- 
 15. Contact telephone number:    00 44 1603 684420 
-------------------------------  --------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLFMGZNRRGGNZG

(END) Dow Jones Newswires

July 28, 2017 04:34 ET (08:34 GMT)

1 Year Faron Pharmaceuticals Oy Chart

1 Year Faron Pharmaceuticals Oy Chart

1 Month Faron Pharmaceuticals Oy Chart

1 Month Faron Pharmaceuticals Oy Chart

Your Recent History

Delayed Upgrade Clock